GMP Factory Supply Cabazitaxel

Short Description:

Cabataxel raw material is a chemical semi-synthetic taxane small molecule compound,mainly used in the production of cabataxel drugs.The mechanism of action of this drug is to act as a microtubule inhibitor,which promotes microtubule polymerization and prevents microtubule depolymerization by binding with microtubule protein,thus inhibiting the mitosis of tumor cells,effectively shrinking the tumor and delaying the deterioration of the disease.


Product Detail

Product Tags

Product Informations

Name: Cabazitaxel

CAS number: 183133-96-2

Chemical formula: C45H57NO14

Specifications: 99%

Color: white or off-white powder

Source: Semi-synthesized with 10-DAB

Type: APIs

Effect

Carbataxel raw material is a pharmaceutical raw material whose main active ingredient is carbataxel.Carbataxel is a drug used in the treatment of cancer and is particularly suitable for treating advanced prostate cancer.It belongs to a class of drugs known as"paclitaxel analogues"(Taxane class of drugs)that inhibit the division and growth of cancer cells by affecting the structure of cell microtubules.By interacting with microtubules within cancer cells,carbataxel stops the cells from dividing normally,thus slowing the growth and spread of cancer.

The benefits of carbataxel are not limited to prostate cancer.Clinical trials have proven that it can also shrink tumors and slow the growth or spread of tumors to ease symptoms of prostate cancer and improve patients'quality of life.In addition,carbaxel has antitumor activity in tumors that are not sensitive to docetaxel chemotherapy.

Our Services

1.Products:Provide high-quality,high-purity plant extracts,pharmaceutical raw materials,and pharmaceutical intermediates.

2.Technical services:Customized extracts with special specifications according to customer requirements.

Hande factory

Be the best supplier of raw materials and enterprises with integrity!

Welcome to contact me by sending email to marketing@handebio.com


  • Previous:
  • Next: